CIK 0001520262
- Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981007018
- Phone
- +353 17728000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $697,937
- in 4 filings, $698K under 10b5-1 plans
Net −$697,937. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-12-12 | ANSTICE DAVID W Director | Sale | −3,552 | $35.61 | $126K | 66,448 |
| 2018-12-12 | ANSTICE DAVID W Director | Sale | −235 | $35.92 | $8K | 66,213 |
| 2018-12-12 | ANSTICE DAVID W Director | Exercise or conversion | +5,000 | $8.98 | $45K | 71,213 |
| 2018-12-12 | ANSTICE DAVID W Director | Sale | −5,000 | $35.56 | $178K | 66,213 |
| 2018-12-12 | ANSTICE DAVID W Director | Exercise or conversion · Non Qualified Stock Option (Right to Buy) | −15,000 | 5,000 | ||
| 2018-12-12 | ANSTICE DAVID W Director | Exercise or conversion · Non Qualified Stock Option (Right to Buy) | −5,000 | 0 | ||
| 2018-12-07 | POPS RICHARD F Director and CEO, Alkermes plc | Grant or award | +27,500 | 693,852 | ||
| 2018-12-07 | POPS RICHARD F Director and CEO, Alkermes plc | Shares withheld for taxes | −12,224 | $34.01 | $416K | 681,628 |
| 2018-12-07 | LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. | Grant or award | +5,500 | 178,144 | ||
| 2018-12-07 | LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. | Shares withheld for taxes | −2,445 | $34.01 | $83K | 175,699 |
| 2018-12-07 | Hopkinson Craig C. SVP, Med Dev/Med Affairs, CMO | Grant or award | +4,000 | 4,881 | ||
| 2018-12-07 | Hopkinson Craig C. SVP, Med Dev/Med Affairs, CMO | Shares withheld for taxes | −1,178 | $34.01 | $40K | 3,703 |
| 2018-12-07 | Gaffin David Joseph SVP, CLO, Alkermes, Inc. | Grant or award | +5,500 | 42,138 | ||
| 2018-12-07 | Gaffin David Joseph SVP, CLO, Alkermes, Inc. | Shares withheld for taxes | −1,620 | $34.01 | $55K | 40,518 |
| 2018-12-07 | FRATES JAMES M SVP, Alks Inc; CFO ALKS | Grant or award | +5,500 | 42,734 | ||
| 2018-12-07 | FRATES JAMES M SVP, Alks Inc; CFO ALKS | Shares withheld for taxes | −2,445 | $34.01 | $83K | 40,289 |
| 2018-12-07 | Brown Iain Michael SVP Finance & CAO, Alks Inc. | Grant or award | +4,000 | 25,895 | ||
| 2018-12-07 | Brown Iain Michael SVP Finance & CAO, Alks Inc. | Shares withheld for taxes | −1,178 | $34.01 | $40K | 24,717 |
| 2018-12-03 | MITCHELL PAUL J Director | Exercise or conversion | +1,000 | $8.98 | $9K | 1,000 |
| 2018-12-03 | MITCHELL PAUL J Director | Sale | −1,000 | $36.45 | $36K | 0 |
Page 87 of 90 · 1,796 trades